Anti-Retroviral regulatory update

Ranbaxy made 3 filings of its ARV agents to the World Health Organization (WHO) for its approvals. Earlier, Ranbaxy submitted 4 ANDAs to the FDA including 3 ARV oral tablets, lamivudine, nevirapine an...